Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
General Biologicals Corporation engages in the research, development, manufacture, and sales of in-vitro diagnostics in Taiwan and internationally. It offers ELISA and chemiluminescence immunoassay, molecular and cell diagnostic, and point of care testing services. The company also provides COVID-19, digital pathology, and contract development manufacturing organization solutions; blood screening services for hepatitis and HIV; and biomaterial, such as antibody biomaterials and human plasma. In addition, it offers a range of oral care products under the oh care brand. Further, the company serves its diagnostic solutions through clinics and laboratories. General Biologicals Corporation was founded in 1973 and is headquartered in Hsinchu City, Taiwan.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers.
Buy
Sell